Hendaye, France

Mathieu Argudo

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Suricog, Sas. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Mathieu Argudo

Introduction

Mathieu Argudo is a notable inventor based in Hendaye, France. He has made significant contributions to the field of oculomotor research, particularly through his innovative patent that addresses abnormalities in eye movement. His work is essential for advancing our understanding of visual and neurological functions.

Latest Patents

Argudo holds a patent titled "Method and system for revealing oculomotor abnormalities." This invention includes a system designed to demonstrate oculomotor abnormalities in eukaryotes. The system comprises elements for capturing eye movements while the subject is stimulated with images, an analysis module for calculating predetermined parameters, and elements for determining abnormalities based on the calculated values.

Career Highlights

Throughout his career, Mathieu Argudo has worked with various companies, including Suricog and Sas. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in his field.

Collaborations

Argudo has collaborated with notable individuals such as Serge Kinkingnehun and Mickael Maillard. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Mathieu Argudo's innovative contributions to the field of oculomotor research highlight his expertise and dedication as an inventor. His patent serves as a valuable tool for understanding eye movement abnormalities, showcasing the importance of his work in advancing scientific knowledge.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…